Molina Healthcare (MOH) – Analysts’ Weekly Ratings Updates

Molina Healthcare (NYSE: MOH) has recently received a number of price target changes and ratings updates:

• 10/25/2025 – Molina Healthcare was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating.
• 10/24/2025 – Molina Healthcare was given a new $175.00 price target on by analysts at Truist Financial Corporation.
• 10/24/2025 – Molina Healthcare was given a new $158.00 price target on by analysts at Morgan Stanley.
• 10/24/2025 – Molina Healthcare had its price target lowered by analysts at UBS Group AG from $180.00 to $170.00. They now have a “neutral” rating on the stock.
• 10/24/2025 – Molina Healthcare had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $207.00 to $167.00. They now have a “neutral” rating on the stock.
• 10/24/2025 – Molina Healthcare was given a new $165.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.
• 10/24/2025 – Molina Healthcare had its price target lowered by analysts at Cantor Fitzgerald from $210.00 to $180.00. They now have a “neutral” rating on the stock.
• 10/24/2025 – Molina Healthcare had its “underweight” rating reaffirmed by analysts at Barclays PLC. They now have a $144.00 price target on the stock, down previously from $185.00.
• 10/16/2025 – Molina Healthcare was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $203.00 price target on the stock.
• 10/14/2025 – Molina Healthcare was given a new $210.00 price target on by analysts at Truist Financial Corporation.
• 10/14/2025 – Molina Healthcare had its price target raised by analysts at Morgan Stanley from $163.00 to $204.00. They now have an “equal weight” rating on the stock.
• 10/14/2025 – Molina Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $207.00 price target on the stock.
• 10/14/2025 – Molina Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $207.00 price target on the stock.
• 10/8/2025 – Molina Healthcare had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Molina Healthcare had its price target raised by analysts at Wells Fargo & Company from $198.00 to $231.00. They now have an “overweight” rating on the stock.
• 9/27/2025 – Molina Healthcare had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
• 9/5/2025 – Molina Healthcare had its price target lowered by analysts at Sanford C. Bernstein from $284.00 to $220.00. They now have an “outperform” rating on the stock.
• 9/4/2025 – Molina Healthcare had its price target lowered by analysts at Barclays PLC from $186.00 to $185.00. They now have an “equal weight” rating on the stock.

Insider Activity at Molina Healthcare

In other news, Director Ronna Romney sold 700 shares of the company’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the sale, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.10% of the stock is owned by company insiders.

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.